# A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation

Study · id `cardio:ct-nct02513810` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02513810](<https://clinicaltrials.gov/study/NCT02513810>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02513810

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3020 participants.

## Technical summary

Registry record NCT02513810. Randomized; no masking; primary purpose treatment. Start 2015-12-02 (actual); primary completion 2019-09-17 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3020 participants (planned count; ClinicalTrials.gov record NCT02513810, source copy `cardio:ctgov-nct02513810-2020-03-04`, retrieved 2026-10-26)
- Started: 2015-12-02 (actual) (ClinicalTrials.gov record NCT02513810, source copy `cardio:ctgov-nct02513810-2020-03-04`, retrieved 2026-10-26)
- Primary completion: 2019-09-17 (actual) (ClinicalTrials.gov record NCT02513810, source copy `cardio:ctgov-nct02513810-2020-03-04`, retrieved 2026-10-26)
- Completion: 2020-09 (anticipated) (ClinicalTrials.gov record NCT02513810, source copy `cardio:ctgov-nct02513810-2020-03-04`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02513810, source copy `cardio:ctgov-nct02513810-2020-03-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02513810-2020-03-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation
- Condition: Coronary Artery Disease
- Intervention (Device): BioFreedom with 1 month DAPT
- Intervention (Device): BioMatrix or Ultimaster with 6 to 12 months DAPT
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation: One-Month DAPT Trial (`cardio:pubmed-34332946`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial (`cardio:pubmed-35470799`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 165c716177a94d4b501095d13f41b8836101b150bc02619eec89b955cc511c2f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
